大规模的有机体表型确定了与代谢相关的NASH遗传易感性
Masaki Kimura1, Takuma Iguchi1, Kentaro Iwasawa1
1Division of Gastroenterology, Hepatology and Nutrition, Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Cell
|October 14, 2022
概括
使用人类器官的非酒精性脂肪肝 (NASH) 遗传学研究显示,GCKR-rs1260326变种根据代谢状态不同地影响疾病的严重程度,提供了新的治疗见解.
科学领域:
- 遗传学和基因组学
- 代谢疾病
- 机器人技术
背景情况:
- 在非酒精性脂肪肝炎 (NASH) 中研究基因型-表型关联,使用组合的人类器官组.
- 专注于代谢状态,特别是胰岛素不敏感性,对遗传因素的预测的影响.
相关概念视频
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...


